Collagen in skincare — what topical products can and cannot do.

Collagen is the most frequently marketed protein in skincare, appearing on product labels for everything from moisturisers to serums to masks, and increasingly in ingestible supplements. The premise is simple and appealing: as the skin's collagen degrades with age, applying it should restore what is lost. The reality of how collagen works in the skin, and what topical and ingestible products can actually do, is considerably more specific.

What collagen is

Collagen is a family of structural proteins — there are at least 28 types, with type I collagen being by far the most abundant in the skin. It is produced by fibroblasts in the dermis (the deeper layer of the skin beneath the epidermis) and forms long, cross-linked fibres that give skin its tensile strength, firmness, and elasticity.

Collagen fibres are not on the skin's surface. They are deep in the dermis, embedded in the extracellular matrix alongside elastin and glycosaminoglycans. This distinction is central to understanding why topical collagen is largely ineffective, and why some interventions — retinoids, vitamin C — are more relevant than others.

The problem with topical collagen

The molecule is too large to penetrate. Collagen is a very large protein — typically around 300kDa. The skin's barrier effectively excludes molecules above about 500Da (daltons). A collagen molecule in a moisturiser sits on the skin's surface, where it acts as an emollient — it improves the texture and feel of the skin — but it does not penetrate to the dermis where structural collagen loss occurs.

This is not a controversial claim. The inability of intact collagen molecules to cross the skin barrier is well-established biophysics.

Hydrolysed collagen — smaller, but still limited. Hydrolysed collagen (collagen peptides) breaks the protein into smaller fragments — peptides with molecular weights in the range of 1,000–10,000Da. These are smaller than intact collagen but still large relative to the skin's permeability threshold. Some smaller fragments may penetrate the epidermis; the evidence that they reach the dermis and stimulate fibroblast collagen production is promising but not conclusive in independent research.

The surface function is real. Collagen as a film-forming agent on the skin surface genuinely improves texture, creates a temporary plumping effect, and can reduce the transient appearance of fine lines — for as long as the film is present. This is an immediate, cosmetically useful effect. It is not the same as structural collagen restoration.

What actually does support collagen in the dermis

Retinoids. Topical retinoids — particularly tretinoin, but also retinol at sufficient concentration — are the most evidence-backed topical intervention for increasing dermal collagen production. They activate nuclear receptors in fibroblasts, upregulating collagen synthesis genes. The effect on collagen quantity and skin thickness is measurable over months of consistent use. Retinoids also reduce collagen-degrading enzymes (matrix metalloproteinases) that increase with UV exposure.

Vitamin C. L-ascorbic acid is required for the hydroxylation of proline and lysine, amino acids essential to stable collagen structure. Without vitamin C, collagen cannot be properly synthesised. Topically, L-ascorbic acid at clinically relevant concentrations (10–20% at low pH) has been shown to stimulate collagen gene expression in dermal fibroblasts and measurably improve skin firmness over months.

Peptides. Certain peptides — notably palmitoyl pentapeptide-4 (Matrixyl) and some copper peptides — signal fibroblasts to increase collagen production. The evidence is positive for specific peptides at sufficient concentrations. The category is oversold as a whole, but the specific evidence for signal and carrier peptides is meaningful.

Sunscreen. UV radiation is the primary driver of collagen degradation in the dermis. UVA penetrates to the dermis and activates matrix metalloproteinases, the enzymes that break down collagen fibres. Daily broad-spectrum SPF prevents this degradation. It does not restore collagen; it protects what remains.

Ingestible collagen — the evidence

Oral collagen peptides — hydrolysed to di- and tripeptides — are absorbed through the gut, enter circulation, and some fraction appears to deposit in the skin's extracellular matrix or stimulate fibroblasts. A growing body of randomised controlled trials has found measurable improvements in skin hydration, elasticity, and the appearance of fine lines with consistent oral collagen supplementation (typically 2.5–10g/day for eight to twelve weeks).

The evidence is more robust than for topical collagen — oral absorption is not limited by the skin barrier — but the quality of individual studies varies, and many are funded by supplement manufacturers. Independent replication of the most positive findings is ongoing. The current picture: meaningful evidence for modest benefits in skin hydration and elasticity; less certainty on collagen density specifically.

What collagen products cannot do

Topical or ingestible collagen will not reverse significant structural skin changes — deep folds, substantial volume loss, or the firmness changes associated with advanced skin ageing. Those changes reflect decades of collagen loss combined with fat redistribution and bone resorption — processes that are not addressable by surface or gut-absorbed interventions. Medical aesthetic procedures (radiofrequency, ultrasound, fillers, laser) target the dermis directly and produce effects that topical products cannot match.

Collagen-labelled products are not harmful. The expectation they are sold with is often disproportionate to what the category can deliver.

The Lux & Glo position

The ritual is built around the barrier, not around anti-ageing intervention. Niacinamide supports ceramide synthesis — the barrier function. Squalane and shea butter reinforce the lipid matrix. None of the three steps targets collagen directly.

For collagen support beyond the ritual: a vitamin C product in the morning is the most accessible, well-evidenced topical addition. A retinoid in the evening is the most significant active intervention available without a prescription. Both require a stable barrier baseline before introduction — which is what the three steps provide.

Understanding collagen is understanding the gap between what is marketed and what is possible. That gap is where real decisions are made.